What if you could help fund a cure for coronavirus?
Drug Innovation Ventures at Emory (DRIVE) is a not-for-profit biotechnology company, founded to discover and develop antiviral drugs to anticipate and help end deadly pandemics and outbreaks caused by viruses.
Today, DRIVE has the most promising potential antiviral therapeutic for coronavirus that can be taken as a pill, making it easy to disseminate, a critical aspect in containing a pandemic. This is unique over a related promising drug currently being tested in China that must be administered intravenously in a hospital setting. To date, our treatment has been proven successful in animal trials. We are on the verge of human testing.
We’ve used funds from Emory University, the U.S. government and our past successes to develop promising antiviral treatments that have the potential to end the new coronavirus. But we have gaps in our funding that require emergency support given the pace of the current COVID-19 outbreak and need your help to get our antivirals rapidly and safely approved.
Please support us in waging war against pandemics and our fight to help end the current coronavirus by donating now.
More about DRIVE
DRIVE focuses on what the world needs, not what makes the most money. As a non-profit company owned by Emory University, DRIVE’s only mission is to develop antiviral drugs that save lives and help end worldwide pandemics and viral threats, such as the novel coronavirus.